Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GERMAIN: Lenalidomide Maintenance vs Placebo after VMP in Newly Diagnosed Multiple Myeloma
NCT02145598Phase 3Terminated
- Start
- Aug 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide in multiple myeloma (MM). Started Aug 2013; status: terminated.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02145598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145598.